FDA authorized the Illumina COVIDSeq Test for the qualitative detection of SARS-CoV-2 RNA from the specimen of COVID-19 suspect.
COVIDSeq is only authorized for use in laboratories in the U.S., certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA)
https://www.biospectrumasia.com/news/83/16112/fda-issues-eua-to-first-next-gen-sequence-test-for-covid-19.html |